Area of research
Transplantation · Surgery
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes, Organ Donation and Transplantation, and Pancreatic function and diabetes.
Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patients
Safety of Kidney Transplantation from Donors with HIV
A2/A2B to B deceased donor kidney transplantation in the Kidney Allocation System era
Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia.
Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act
Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial.
The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients
Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study.
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action
Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection
Outcomes of donor-derived superinfection screening in HIV-positive to HIV-positive kidney and liver transplantation: a multicentre, prospective, observational study
Similar Frequency and Inducibility of Intact Human Immunodeficiency Virus-1 Proviruses in Blood and Lymph Nodes
Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site.
Frailty and Access to Kidney Transplantation
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States
Prehabilitation prior to kidney transplantation: Results from a pilot study
Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients With End-stage Renal Disease in a Prospective Cohort Study
Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor–recipient combination
Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act
Frailty and Postkidney Transplant Health-Related Quality of Life
Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation
The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation
Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients
Changes in Discard Rate After the Introduction of the Kidney Donor Profile Index (KDPI)